Nov 26, 2025 · Keytruda (pembrolizumab) is a PD-1 inhibitor used to treat multiple cancers, including melanoma, lung cancer, breast cancer, and more. Learn about how it works, FDA approvals, dosing, …

Aug 21, 2025 · Keytruda is a brand-name infusion approved to treat several types of cancer. Learn about side effects, warnings, dosage, and more.

TREATS 18 TYPES OF CANCER, INCLUDING CERTAIN EARLY-STAGE AND ADVANCED CANCERS ONE OF THOSE CANCERS IS EARLY-STAGE NON—SMALL CELL LUNG CANCER (NSCLC) IT’S TRU. …

Pembrolizumab works by binding to the protein PD-1 on the surface of certain immune cells called T cells, which keeps cancer cells from suppressing the immune system. This allows the immune …

Dec 18, 2024 · Overview: Keytruda is used to treat many types of cancer. The medicine helps to turn on the body's immune system, so it can attack cancer cells. Common side effects of Keytruda include …

Keytruda (pembrolizumab) is a cancer chemotherapy drug that treats melanoma, lung cancer, and a host of other malignancies. It is often used in combination with other chemotherapy agents, …

5 days ago · KEYTRUDA as monotherapy is also approved in the U.S., EU, Japan and other countries for the treatment of certain patients with la/mUC or a type of non-muscle-invasive bladder cancer (NMIBC).

5 days ago · The combination of Keytruda and Padcev is taking another major step toward securing its position as a leading therapy in the treatment of bladder cancer. The PD-1/antibody-drug conjugate …

5 days ago · PADCEV plus Keytruda is the first and only regimen without platinum-based chemotherapy to improve event-free and overall survival when used before and after...

6 days ago · Separately, Merck is also testing Keytruda in another perioperative MIBC trial, Keynote-866, which pits a chemo combo against neoadjuvant chemo. However, that appears to have been delayed, …